Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
137M
-
Shares change
-
-2.08M
-
Total reported value, excl. options
-
$748M
-
Value change
-
-$24.9M
-
Put/Call ratio
-
0.79
-
Number of buys
-
77
-
Number of sells
-
-49
-
Price
-
$5.46
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q2 2016
166 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q2 2016.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 137M shares
of 309M outstanding shares and own 44.33% of the company stock.
Largest 10 shareholders include FMR LLC (19M shares), PERCEPTIVE ADVISORS LLC (15.2M shares), Redmile Group, LLC (11.1M shares), VANGUARD GROUP INC (7.03M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.88M shares), BlackRock Fund Advisors (5.79M shares), JANUS CAPITAL MANAGEMENT LLC (5.56M shares), JENNISON ASSOCIATES LLC (5.15M shares), SECTORAL ASSET MANAGEMENT INC (4.79M shares), and STATE STREET CORP (4.48M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.